Screening and Early Diagnosis of Hepatocellular Cancer and Optimization of Diagnostic Imaging Techniques: A Review and Conclusion of the Expert Panel

Screening and Early Diagnosis of Hepatocellular Cancer and Optimization of Diagnostic Imaging Techniques: A Review and Conclusion of the Expert Panel

Аim: to describe modern approaches for screening and early diagnosis of hepatocellular carcinoma (HCC).Key points. Screening for HCC in high-risk groups (cirrhosis of any etiology, patients with chronic viral hepatitis B and patients with F3 liver fibrosis) should be organized as regular (every 6 mo...

Full description

Bibliographic Details
Main Authors:	V. V. Breder, R. B. Alikhanov, S. S. Bagnenko, E. N. Bessonova, V. A. Isakov, N. E. Kudashkin, B. M. Medvedeva, A. V. Mishchenko, M. S. Novruzbekov, V. S. Rudakov
Format:	Article
Language:	Russian
Published:	Gastro LLC 2023-02-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	hepatocellular carcinoma liver cancer mri hepatospecific contrast screening early diagnosis gadoxetic acid
Online Access:	https://www.gastro-j.ru/jour/article/view/814

Similar Items

MRI characterization of focal liver lesions in non-cirrhotic patients: assessment of added value of gadoxetic acid-enhanced hepatobiliary phase imaging
by: Bardia Moosavi, et al.
Published: (2020-09-01)

The Influence of Gd-EOB-DTPA on T2 Signal Behavior: An Example from Clinical Routine
by: Paola Franceschi, et al.
Published: (2022-07-01)

Liver-specific gadoxetic acid-enhanced magnetic resonance for focal lesion evaluation
by: P.E. Cossio-Torrico, et al.
Published: (2015-10-01)

Imaging biomarkers for well and moderate hepatocellular carcinoma: preoperative magnetic resonance image and histopathological correlation
by: Kun Huang, et al.
Published: (2019-04-01)

Comparison of gadoxetic acid and gadobenate dimeglumine, liver-specific contrast agents used in magnetic resonance imaging in differential diagnosis of liver masses
by: Mehmet Akcicek, et al.
Published: (2020-03-01)

Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only—A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort
by: Max Seidensticker, et al.
Published: (2022-01-01)

Magnetic resonance imaging of liver tumors using gadoxetic acid (Gd-EOB-DTPA) - pilot study
by: Pola Borusewicz, et al.
Published: (2019-08-01)

Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma
by: Jens Ricke, et al.
Published: (2020-12-01)

Liver Functional Evaluation Using Gadoxetic Acid Versus the Gold Standard Hepatobiliary Scintigraphy in Patients with Bile Duct Diseases
by: M. A. Shorikov, et al.
Published: (2019-09-01)

Gadolinium deposition in the liver and brain in a rat model with liver fibrosis after intravenous administration of gadoxetate disodium
by: Peiying Wei, et al.
Published: (2024-03-01)

Gadolinium-ethoxybenzyl-diethylenetriamine (Gd-EOB-DTPA)- enhanced magnetic resonance imaging with various enhancement ratios: a correlation with clinical assessment of liver function using the Child-Pugh scoring system
by: Łukasz Wypchło, et al.
Published: (2021-12-01)

Radiomics nomogram for prediction of microvascular invasion in hepatocellular carcinoma based on MR imaging with Gd-EOB-DTPA
by: Shuai Zhang, et al.
Published: (2022-11-01)

Peritumoral Dilation Radiomics of Gadoxetate Disodium-Enhanced MRI Excellently Predicts Early Recurrence of Hepatocellular Carcinoma without Macrovascular Invasion After Hepatectomy
by: Chong H, et al.
Published: (2021-06-01)

Evaluation of hepatic findings by magnetic resonance after use of gadoxetic acid
by: Marina Cabral deAlmeida, et al.
Published: (2021-03-01)

Accuracy of Various Forms of Contrast-Enhanced MRI for Diagnosing Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
by: Chun Zhao, et al.
Published: (2021-12-01)

Predictors of changes in preoperative tumor stage between dynamic computed tomography and gadoxetate disodium-enhanced magnetic resonance imaging for hepatocellular carcinoma
by: Chih-Horng Wu, et al.
Published: (2022-08-01)

Preoperative Prediction of Cytokeratin 19 Expression for Hepatocellular Carcinoma with Deep Learning Radiomics Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging
by: Chen Y, et al.
Published: (2021-07-01)

Gadoxetic acid–enhanced MRI with a focus on LI-RADS v2018 imaging features predicts the prognosis after radiofrequency ablation in small hepatocellular carcinoma
by: Ruizhi Wang, et al.
Published: (2023-02-01)

Predictive models and early postoperative recurrence evaluation for hepatocellular carcinoma based on gadoxetic acid-enhanced MR imaging
by: Qian Li, et al.
Published: (2023-01-01)

Hepatocellular carcinoma composed of two different histologic types: imaging features on gadoxetic acid-enhanced liver MRI
by: Seung Hyun Kim, et al.
Published: (2013-03-01)

Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance
by: Khalaf AM, et al.
Published: (2018-06-01)

Determination of hepatic extraction fraction with gadoxetate low‐temporal resolution DCE‐MRI‐based deconvolution analysis: validation with ALBI score and Child‐Pugh class
by: Monchai Phonlakrai, et al.
Published: (2023-04-01)

Development and External Validation of a Radiomics Model Derived from Preoperative Gadoxetic Acid-Enhanced MRI for Predicting Histopathologic Grade of Hepatocellular Carcinoma
by: Xiaojun Hu, et al.
Published: (2023-01-01)

HEPATOCELLULAR CARCINOMA AS A SOCIAL AND MEDICAL PROBLEM IN THE RUSSIAN FEDERATION
by: V. V. BREDER, et al.
Published: (2016-12-01)

Differentiation of Small Hepatocellular Carcinoma From Dysplastic Nodules in Cirrhotic Liver: Texture Analysis Based on MRI Improved Performance in Comparison Over Gadoxetic Acid-Enhanced MR and Diffusion-Weighted Imaging
by: Xi Zhong, et al.
Published: (2020-01-01)

Prediction of microvascular invasion in hepatocellular carcinoma based on preoperative Gd-EOB-DTPA-enhanced MRI: Comparison of predictive performance among 2D, 2D-expansion and 3D deep learning models
by: Tao Wang, et al.
Published: (2023-02-01)

Correction of Arterial-Phase Motion Artifacts in Gadoxetic Acid-Enhanced Liver MRI Using an Innovative Unsupervised Network
by: Feng Pan, et al.
Published: (2023-10-01)

Dynamic PET/CT with the Hepatobiliary Tracer [68Ga]Ga-Tmos-DAZA for Characterization of a Hepatic Tumor
by: Martin Freesmeyer, et al.
Published: (2021-04-01)

Effect of Gadoxetic Acid on Quantification of Hepatic Steatosis Using Magnetic Resonance Spectroscopy: A Prospective Study
by: Ju Won Kim, et al.
Published: (2017-04-01)

A Slowly Growing Mass Around a Cirrhotic Liver: Usefulness of the Hepatobiliary Phase in the Diagnosis of Ectopic Liver
by: Soo Jung Kim, et al.
Published: (2017-08-01)

Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017)
by: Ying Ding, et al.
Published: (2018-12-01)

Evaluation of high temporal resolution magnetic resonance imaging of the liver with gadoxetate disodium in combination with compressed sensing and parallel imaging under single breath-holding using a 1.5-T magnetic resonance system
by: Fumiaki Fukamatsu, et al.
Published: (2024-03-01)

The imaging findings of Peliosis hepatis on gadoxetic acid enhanced MRI
by: Morikatsu Yoshida, MD, et al.
Published: (2020-08-01)

Intraluminal Duodenal Diverticulum: CT and Gadoxetic Acid-Enhanced MRI Findings
by: Jeong Myeong Kim, et al.
Published: (2015-03-01)

Pharmacoeconomic Study on the Application of Magnetic Resonance Imaging with Gadoxetic Acid in Addition to Contrast-Enhanced Computed Tomography in Diagnosis of Hepatocellular Carcinoma
by: G. G. Kаrmаzаnovsky, et al.
Published: (2021-11-01)

Oncological care for the patients with hepatocellular carcinoma in COVID-19 pandemic
by: V. V. Petkau, et al.
Published: (2020-07-01)

Comparison of <sup>68</sup>Ga-DOTATATE Positron Emmited Tomography/Computed Tomography and Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Detection of Liver Metastases from Well-Differentiated Neuroendocrine Tumors
by: Moran Drucker Iarovich, et al.
Published: (2024-01-01)

Assessment of Liver Metastases Using CT and MRI Scans in Patients with Pancreatic Ductal Adenocarcinoma: Effects of Observer Experience on Diagnostic Accuracy
by: Masakatsu Tsurusaki, et al.
Published: (2020-06-01)

Use of In Vivo Imaging and Physiologically-Based Kinetic Modelling to Predict Hepatic Transporter Mediated Drug–Drug Interactions in Rats
by: Nicola Melillo, et al.
Published: (2023-03-01)

Focal nodular hyperplasia after oxaliplatin-based chemotherapy: A diagnostic challenge☆
by: Lorenzo Vassallo, MD, et al.
Published: (2022-06-01)